A cross-sectional study in Saudi Arabia looks at what adults know and think about antidiabetic medications taken for weight loss, and how many use them.
Recap by typeshit. Full story at Cureus.
Researchers are studying whether GLP-1 drugs, which act on mood, appetite and reward pathways, could help with depression, addiction and binge eating.
A retrospective cohort checks whether retinal disease started or worsened more in established users than in people never on either drug, plus a regional NAION review.
24:34
An animated explainer walking through what semaglutide does in the body, from appetite signals in the brain to digestion and blood sugar control.
A CHEST 2026 records analysis of roughly 2 million patients found 1.4% versus 2.3% at one year. The authors say it shows an association, not proof the drugs caused it.
In 485 insulin-naive type 2 diabetes patients, icodec plus semaglutide cut HbA1c more and trimmed weight while glargine users gained 3.81 kg, though GI side effects ran higher.
News-Medical reports that the diabetes and weight loss medicines may also lower the chance of serious complications in the recovery period after an operation.
Loading…